NYU Langone Health and Dana-Farber Cancer Institute have co-developed the Solavia Decision Suite, an oncology decision support platform designed to deliver precise, evidence-based, and standardized care delivery at scale.
Solavia launched internally at NYU Langone on June 30, 2026, and is now commercially available to external health systems and oncology centers.
Beyond streamlining individual appointments, the system helps health systems reduce treatment variation across multidisciplinary teams by standardizing pathway delivery based on each patient's genetic and clinical profile.
It also establishes an operational foundation for learning health systems, offering structured frameworks for pathway digitization and clinical governance that can eventually extend to other specialties.
The suite is embedded directly into the electronic health record (EHR), providing clinicians with real-time access to evolving clinical pathways, biomarkers, treatment guidelines, and therapeutic options within existing workflows.
The joint initiative builds on broader learning health system goals, advancing institutional capabilities in product governance, pathway digitization, implementation science, and clinical transformation.
【MORE】